首页 > 最新文献

New biotechnology最新文献

英文 中文
ReViTA: A novel in vitro transcription system to study gene regulation ReViTA:一种研究基因调控的新型体外转录系统
IF 5.4 2区 生物学 Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-09-25 DOI: 10.1016/j.nbt.2023.04.005
Alba Rubio-Canalejas , Lucas Pedraz , Eduard Torrents

ReViTA (Reverse in Vitro Transcription Assay) is a novel in vitro transcription-based method to study gene expression under the regulation of specific transcription factors. The ReViTA system uses a plasmid with a control sequence, the promoter region of the studied gene, the transcription factor of interest, and an RNA polymerase saturated with σ70. The main objective of this study was to evaluate the method; thus, as a proof of concept, two different transcription factors were used, a transcriptional inducer, AlgR, and a repressor, LexA, from Pseudomonas aeruginosa. After the promoters were incubated with the transcription factors, the plasmid was transcribed into RNA and reverse transcribed to cDNA. Gene expression was measured using qRTPCR. Using the ReViTA plasmid, transcription induction of 55% was observed when AlgR protein was added and a 27% transcription reduction with the repressor LexA, compared with the samples without transcription factors. The results demonstrated the correct functioning of ReViTA as a novel method to study transcription factors and gene expression. Thus, ReViTA could be a rapid and accessible in vitro method to evaluate genes and regulators of various species.

ReViTA(Reverse in Vitro Transcription Assay)是一种新的基于体外转录的方法,用于研究特定转录因子调控下的基因表达。ReViTA系统使用具有对照序列的质粒、所研究基因的启动子区、感兴趣的转录因子和饱和σ70的RNA聚合酶。本研究的主要目的是评估该方法;因此,作为概念的证明,使用了两种不同的转录因子,一种是来自铜绿假单胞菌的转录诱导因子AlgR,另一种是阻遏因子LexA。启动子与转录因子孵育后,将质粒转录为RNA并逆转录为cDNA。使用qRTPCR测量基因表达。使用ReViTA质粒,与没有转录因子的样品相比,当添加AlgR蛋白时观察到55%的转录诱导,并且用阻遏物LexA观察到27%的转录减少。结果证明了ReViTA作为一种研究转录因子和基因表达的新方法的正确功能。因此,ReViTA可能是一种快速且可获得的体外评估各种物种的基因和调节因子的方法。
{"title":"ReViTA: A novel in vitro transcription system to study gene regulation","authors":"Alba Rubio-Canalejas ,&nbsp;Lucas Pedraz ,&nbsp;Eduard Torrents","doi":"10.1016/j.nbt.2023.04.005","DOIUrl":"10.1016/j.nbt.2023.04.005","url":null,"abstract":"<div><p>ReViTA (<strong><u>Re</u></strong>verse <em>in <strong><u>Vi</u></strong>tro</em> <strong><u>T</u></strong>ranscription <strong><u>A</u></strong>ssay) is a novel <em>in vitro</em> transcription-based method to study gene expression under the regulation of specific transcription factors. The ReViTA system uses a plasmid with a control sequence, the promoter region of the studied gene, the transcription factor of interest, and an RNA polymerase saturated with σ<sup>70</sup>. The main objective of this study was to evaluate the method; thus, as a proof of concept, two different transcription factors were used, a transcriptional inducer, AlgR, and a repressor, LexA, from <em>Pseudomonas aeruginosa</em>. After the promoters were incubated with the transcription factors, the plasmid was transcribed into RNA and reverse transcribed to cDNA. Gene expression was measured using qRT<img>PCR. Using the ReViTA plasmid, transcription induction of 55% was observed when AlgR protein was added and a 27% transcription reduction with the repressor LexA, compared with the samples without transcription factors. The results demonstrated the correct functioning of ReViTA as a novel method to study transcription factors and gene expression. Thus, ReViTA could be a rapid and accessible <em>in vitro</em> method to evaluate genes and regulators of various species.</p></div>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9647200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Purification of DNA oligonucleotides to improve hybridization chain reaction performance 纯化DNA寡核苷酸以提高杂交链反应性能
IF 5.4 2区 生物学 Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-09-25 DOI: 10.1016/j.nbt.2023.04.004
Mattias Leino, Ola Söderberg

Hybridization Chain Reaction (HCR) is a technique to generate a linear polymerization of oligonucleotide hairpins, used in multiple molecular biology methods. The HCR reaction is dependent on every hairpin being metastable in the absence of a triggering oligonucleotide and that every hairpin can continue the polymerization, which puts a strong demand on oligonucleotide quality. We show how further purification can greatly increase polymerization potential. It was found that a single extra PAGE-purification could greatly enhance hairpin polymerization both in solution and in situ. Purification using a ligation-based method further improved polymerization, yielding in situ immunoHCR stains at least 3.4-times stronger than a non-purified control. This demonstrates the importance of not only good sequence design of the oligonucleotide hairpins, but also the demand for high quality oligonucleotides to accomplish a potent and specific HCR.

杂交链式反应(HCR)是一种产生寡核苷酸发夹线性聚合的技术,用于多种分子生物学方法。HCR反应取决于每个发夹在没有触发寡核苷酸的情况下是可转移的,并且每个发夹都可以继续聚合,这对寡核苷酸的质量提出了强烈的要求。我们展示了进一步纯化可以极大地提高聚合潜力。研究发现,一次额外的PAGE纯化可以大大增强溶液和原位的发夹聚合。使用基于连接的方法纯化进一步改进了聚合,产生的原位免疫HCR染色比未纯化的对照强至少3.4倍。这证明了不仅寡核苷酸发夹的良好序列设计的重要性,而且需要高质量的寡核苷酸来实现有效和特异的HCR。
{"title":"Purification of DNA oligonucleotides to improve hybridization chain reaction performance","authors":"Mattias Leino,&nbsp;Ola Söderberg","doi":"10.1016/j.nbt.2023.04.004","DOIUrl":"10.1016/j.nbt.2023.04.004","url":null,"abstract":"<div><p>Hybridization Chain Reaction (HCR) is a technique to generate a linear polymerization of oligonucleotide hairpins, used in multiple molecular biology methods. The HCR reaction is dependent on every hairpin being metastable in the absence of a triggering oligonucleotide and that every hairpin can continue the polymerization, which puts a strong demand on oligonucleotide quality. We show how further purification can greatly increase polymerization potential. It was found that a single extra PAGE-purification could greatly enhance hairpin polymerization both <em>in solution</em> and <em>in situ</em>. Purification using a ligation-based method further improved polymerization, yielding <em>in situ</em> immunoHCR stains at least 3.4-times stronger than a non-purified control. This demonstrates the importance of not only good sequence design of the oligonucleotide hairpins, but also the demand for high quality oligonucleotides to accomplish a potent and specific HCR.</p></div>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9649122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic code expansion in E. coli enables production of a functional ‘ready-to-click’ T cell receptor-specific scFv 大肠杆菌的遗传密码扩增使生产功能性“随时可点击”的T细胞受体特异性scFv成为可能
IF 5.4 2区 生物学 Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-09-25 DOI: 10.1016/j.nbt.2023.05.007
Rajeev Pasupuleti , Francesca Rosato , Dajana Kolanovic , Olga N. Makshakova , Winfried Römer , Birgit Wiltschi

Antibody-based cancer therapies have been evolving at a rapid pace in the pharmaceutical market. Bispecific antibody-drug conjugates that engage immune cells to target and kill cancer cells with precision have inspired the development of immunotherapy. Miniaturized antibody fragments such as diabodies, nanobodies, or single-chain variable fragments (scFvs) hold great promise as antibody-drug conjugates as they specifically target tumor tissue and can penetrate it. Here, we optimized the soluble periplasmic expression of the scFv OKT3 comprising the variable VH and VL domains of the mouse anti-human CD3 antibody muromonab-CD3 (trade name Orthoclone OKT3) in E. coli. By an expansion of the genetic code, we site-specifically incorporated the reactive non-canonical amino acid Nε-((2-azidoethoxy)carbonyl)-L-lysine (AzK) into scFv OKT3 using an orthogonal pyrrolysyl-tRNA synthetase/tRNACUA pair. To confirm the AzK incorporation and to demonstrate the accessibility of the reactive azide group, we conjugated a fluorophore to scFv OKT3 AzK variants by copper-free strain-promoted alkyne-azide cycloaddition (‘click chemistry’). The scFv OKT3 wild type and the AzK variants bound T cells at nanomolar concentrations. In this study, a ‘ready-to-click’ scFv OKT3 was successfully developed for future applications, e.g. as controlled anti-T cell antibody-drug conjugate or bispecific T cell engager and for imaging immune T cell migration in cancers.

基于抗体的癌症疗法在药物市场上发展迅速。双特异性抗体驱动的偶联物使免疫细胞精确靶向并杀死癌症细胞,这激发了免疫疗法的发展。小型化抗体片段,如双抗体、纳米体或单链可变片段(scFv),作为抗体-药物偶联物具有很大的前景,因为它们特异性靶向肿瘤组织并能穿透肿瘤组织,我们优化了包含小鼠抗人CD3抗体muromonab-CD3(商品名Orthoclone OKT3)的可变VH和VL结构域的scFv OKT3在大肠杆菌中的可溶性周质表达。通过扩展遗传密码,我们使用正交的吡咯烷基tRNA合成酶/tRNACUA对将反应性非经典氨基酸Nε-((2-叠氮氧基)羰基)-L-赖氨酸(AzK)位点特异性地结合到scFv OKT3中。为了证实AzK的掺入并证明反应性叠氮化物基团的可及性,我们通过无铜菌株促进的炔烃叠氮化物环加成将荧光团偶联到scFv OKT3 AzK变体上(“点击化学”)。scFv OKT3野生型和AzK变体以纳摩尔浓度结合T细胞。在这项研究中,成功开发了一种“点击即用”scFv OKT3,用于未来的应用,例如作为对照抗T细胞抗体药物偶联物或双特异性T细胞接合剂,以及用于癌症中免疫T细胞迁移的成像。
{"title":"Genetic code expansion in E. coli enables production of a functional ‘ready-to-click’ T cell receptor-specific scFv","authors":"Rajeev Pasupuleti ,&nbsp;Francesca Rosato ,&nbsp;Dajana Kolanovic ,&nbsp;Olga N. Makshakova ,&nbsp;Winfried Römer ,&nbsp;Birgit Wiltschi","doi":"10.1016/j.nbt.2023.05.007","DOIUrl":"10.1016/j.nbt.2023.05.007","url":null,"abstract":"<div><p>Antibody-based cancer therapies have been evolving at a rapid pace in the pharmaceutical market. Bispecific antibody-drug conjugates that engage immune cells to target and kill cancer cells with precision have inspired the development of immunotherapy. Miniaturized antibody fragments such as diabodies, nanobodies, or single-chain variable fragments (scFvs) hold great promise as antibody-drug conjugates as they specifically target tumor tissue and can penetrate it. Here, we optimized the soluble periplasmic expression of the scFv OKT3 comprising the variable V<sub>H</sub> and V<sub>L</sub> domains of the mouse anti-human CD3 antibody muromonab-CD3 (trade name Orthoclone OKT3) in <em>E. coli</em>. By an expansion of the genetic code, we site-specifically incorporated the reactive non-canonical amino acid N<sup>ε</sup>-((2-azidoethoxy)carbonyl)-<span>L</span>-lysine (AzK) into scFv OKT3 using an orthogonal pyrrolysyl-tRNA synthetase/tRNA<sub>CUA</sub> pair. To confirm the AzK incorporation and to demonstrate the accessibility of the reactive azide group, we conjugated a fluorophore to scFv OKT3 AzK variants by copper-free strain-promoted alkyne-azide cycloaddition (‘click chemistry’). The scFv OKT3 wild type and the AzK variants bound T cells at nanomolar concentrations. In this study, a ‘ready-to-click’ scFv OKT3 was successfully developed for future applications, e.g. as controlled anti-T cell antibody-drug conjugate or bispecific T cell engager and for imaging immune T cell migration in cancers.</p></div>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9650272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An approach to rapid distributed manufacturing of broad spectrum anti-viral griffithsin using cell-free systems to mitigate pandemics 一种使用无细胞系统快速分布式生产广谱抗病毒Griffin的方法,以缓解流行病。
IF 5.4 2区 生物学 Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-09-25 DOI: 10.1016/j.nbt.2023.04.003
Shayan G. Borhani , Max Z. Levine , Lauren H. Krumpe , Jennifer Wilson , Curtis J. Henrich , Barry R. O’Keefe , Donald C. Lo , G. Sitta Sittampalam , Alexander G. Godfrey , R. Dwayne Lunsford , Venkata Mangalampalli , Dingyin Tao , Christopher A. LeClair , Aaron P. Thole , Douglas Frey , James Swartz , Govind Rao

This study describes the cell-free biomanufacturing of a broad-spectrum antiviral protein, griffithsin (GRFT) such that it can be produced in microgram quantities with consistent purity and potency in less than 24 h. We demonstrate GRFT production using two independent cell-free systems, one plant and one microbial. Griffithsin purity and quality were verified using standard regulatory metrics. Efficacy was demonstrated in vitro against SARS-CoV-2 and HIV-1 and was nearly identical to that of GRFT expressed in vivo. The proposed production process is efficient and can be readily scaled up and deployed wherever a viral pathogen might emerge. The current emergence of viral variants of SARS-CoV-2 has resulted in frequent updating of existing vaccines and loss of efficacy for front-line monoclonal antibody therapies. Proteins such as GRFT with its efficacious and broad virus neutralizing capability provide a compelling pandemic mitigation strategy to promptly suppress viral emergence at the source of an outbreak.

这项研究描述了一种广谱抗病毒蛋白griffithsin(GRFT)的无细胞生物制造,使其能够在24小时内以微克的量生产,并具有一致的纯度和效力。我们展示了使用两个独立的无细胞系统,一个植物和一个微生物生产GRFT。Griffithsin的纯度和质量使用标准监管指标进行验证。在体外证明了对严重急性呼吸系统综合征冠状病毒2型和HIV-1的疗效,并且与体内表达的GRFT几乎相同。拟议的生产过程是有效的,可以很容易地扩大规模,并部署在任何可能出现病毒病原体的地方。目前出现的严重急性呼吸系统综合征冠状病毒2型病毒变种导致现有疫苗频繁更新,一线单克隆抗体疗法失去疗效。GRFT等蛋白质具有有效和广泛的病毒中和能力,提供了一种令人信服的疫情缓解策略,可以在疫情爆发时迅速抑制病毒的出现。
{"title":"An approach to rapid distributed manufacturing of broad spectrum anti-viral griffithsin using cell-free systems to mitigate pandemics","authors":"Shayan G. Borhani ,&nbsp;Max Z. Levine ,&nbsp;Lauren H. Krumpe ,&nbsp;Jennifer Wilson ,&nbsp;Curtis J. Henrich ,&nbsp;Barry R. O’Keefe ,&nbsp;Donald C. Lo ,&nbsp;G. Sitta Sittampalam ,&nbsp;Alexander G. Godfrey ,&nbsp;R. Dwayne Lunsford ,&nbsp;Venkata Mangalampalli ,&nbsp;Dingyin Tao ,&nbsp;Christopher A. LeClair ,&nbsp;Aaron P. Thole ,&nbsp;Douglas Frey ,&nbsp;James Swartz ,&nbsp;Govind Rao","doi":"10.1016/j.nbt.2023.04.003","DOIUrl":"10.1016/j.nbt.2023.04.003","url":null,"abstract":"<div><p>This study describes the cell-free biomanufacturing of a broad-spectrum antiviral protein, griffithsin (GRFT) such that it can be produced in microgram quantities with consistent purity and potency in less than 24 h. We demonstrate GRFT production using two independent cell-free systems, one plant and one microbial. Griffithsin purity and quality were verified using standard regulatory metrics. Efficacy was demonstrated <em>in vitro</em> against SARS-CoV-2 and HIV-1 and was nearly identical to that of GRFT expressed <em>in vivo</em>. The proposed production process is efficient and can be readily scaled up and deployed wherever a viral pathogen might emerge. The current emergence of viral variants of SARS-CoV-2 has resulted in frequent updating of existing vaccines and loss of efficacy for front-line monoclonal antibody therapies. Proteins such as GRFT with its efficacious and broad virus neutralizing capability provide a compelling pandemic mitigation strategy to promptly suppress viral emergence at the source of an outbreak.</p></div>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10330340/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9759850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A single-chain variable fragment selected against a conformational epitope of a recombinantly produced snake toxin using phage display 利用噬菌体展示筛选抗重组产生的蛇毒素构象表位的单链可变片段
IF 5.4 2区 生物学 Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-09-25 DOI: 10.1016/j.nbt.2023.04.002
Charlotte Rimbault , Pelle D. Knudsen , Anna Damsbo , Kim Boddum , Hanif Ali , Celeste M. Hackney , Lars Ellgaard , Markus-Frederik Bohn , Andreas H. Laustsen

Phage display technology is a powerful tool for selecting monoclonal antibodies against a diverse set of antigens. Within toxinology, however, it remains challenging to generate monoclonal antibodies against many animal toxins, as they are difficult to obtain from venom. Recombinant toxins have been proposed as a solution to overcome this challenge, but so far, few have been used as antigens to generate neutralizing antibodies. Here, we describe the recombinant expression of α-cobratoxin in E. coli and its successful application as an antigen in a phage display selection campaign. From this campaign, an scFv (single-chain variable fragment) was isolated with similar binding affinity to a control scFv generated against the native toxin. The selected scFv recognizes a structural epitope, enabling it to inhibit the interaction between the acetylcholine receptor and the native toxin in vitro. This approach represents the first entirely in vitro antibody selection strategy for generating neutralizing monoclonal antibodies against a snake toxin.

噬菌体展示技术是选择针对多种抗原的单克隆抗体的有力工具。然而,在毒理学中,产生针对许多动物毒素的单克隆抗体仍然具有挑战性,因为它们很难从毒液中获得。重组毒素已被提出作为克服这一挑战的解决方案,但到目前为止,很少有人被用作产生中和抗体的抗原。在此,我们描述了α-眼镜蛇毒素在大肠杆菌中的重组表达及其作为抗原在噬菌体展示选择活动中的成功应用。从该活动中,分离出与针对天然毒素产生的对照scFv具有相似结合亲和力的scFv(单链可变片段)。所选择的scFv识别结构表位,使其能够在体外抑制乙酰胆碱受体和天然毒素之间的相互作用。这种方法代表了第一种完全在体外产生针对蛇毒素的中和单克隆抗体的抗体选择策略。
{"title":"A single-chain variable fragment selected against a conformational epitope of a recombinantly produced snake toxin using phage display","authors":"Charlotte Rimbault ,&nbsp;Pelle D. Knudsen ,&nbsp;Anna Damsbo ,&nbsp;Kim Boddum ,&nbsp;Hanif Ali ,&nbsp;Celeste M. Hackney ,&nbsp;Lars Ellgaard ,&nbsp;Markus-Frederik Bohn ,&nbsp;Andreas H. Laustsen","doi":"10.1016/j.nbt.2023.04.002","DOIUrl":"10.1016/j.nbt.2023.04.002","url":null,"abstract":"<div><p>Phage display technology is a powerful tool for selecting monoclonal antibodies against a diverse set of antigens. Within toxinology, however, it remains challenging to generate monoclonal antibodies against many animal toxins, as they are difficult to obtain from venom. Recombinant toxins have been proposed as a solution to overcome this challenge, but so far, few have been used as antigens to generate neutralizing antibodies. Here, we describe the recombinant expression of α-cobratoxin in <em>E. coli</em> and its successful application as an antigen in a phage display selection campaign. From this campaign, an scFv (single-chain variable fragment) was isolated with similar binding affinity to a control scFv generated against the native toxin. The selected scFv recognizes a structural epitope, enabling it to inhibit the interaction between the acetylcholine receptor and the native toxin <em>in vitro</em>. This approach represents the first entirely <em>in vitro</em> antibody selection strategy for generating neutralizing monoclonal antibodies against a snake toxin.</p></div>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10004828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Influence of feedstock source on the development of polyhydroxyalkanoates-producing mixed microbial cultures in continuously stirred tank reactors 原料来源对在连续搅拌釜式反应器中生产混合微生物培养物的聚羟基烷酸酯发展的影响
IF 5.4 2区 生物学 Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-09-25 DOI: 10.1016/j.nbt.2023.05.005
Elisa Clagnan, Fabrizio Adani

Polyhydroxyalkanoates (PHAs) are the new frontier of bioplastic production; however, research is needed to develop and characterise efficient mixed microbial communities (MMCs) for their application with a multi-feedstock approach. Here, the performance and composition of six MMCs developed from the same inoculum on different feedstocks were investigated through Illumina sequencing to understand community development and identify possible redundancies in terms of genera and PHA metabolism. High PHA production efficiencies (>80% mg CODPHA mg-1 CODOA-consumed) were seen across all samples, but differences in the organic acids (OAs) composition led to different ratios of the monomers poly(3-hydroxybutyrate) (3HB) to poly(3-hydroxyvalerate) (3HV). Communities differed across all feedstocks, with enrichments in specific PHA-producing genera, but analysis of potential enzymatic activity identified a certain degree of functional redundancy, possibly leading to the general high efficiency seen in PHA production from all feedstocks. Leading PHAs producers across all feedstocks were identified in genera such as Thauera, Leadbetterella, Neomegalonema and Amaricoccus.

聚羟基烷酸酯(PHA)是生物塑料生产的新前沿;然而,需要研究开发和表征有效的混合微生物群落(MMCs),以便通过多原料方法进行应用。在这里,通过Illumina测序研究了在不同原料上由相同接种物开发的六种MMC的性能和组成,以了解群落发育,并确定属和PHA代谢方面可能的冗余。在所有样品中都观察到高的PHA生产效率(>;消耗80%mg CODPHA mg-1 CODOA),但有机酸(OA)组成的差异导致单体聚(3-羟基丁酸酯)(3HB)与聚(3-羟戊酸酯)(3HV)的比例不同。所有原料的群落不同,在特定的PHA生产属中富集,但对潜在酶活性的分析发现了一定程度的功能冗余,可能导致所有原料的PHA生产普遍高效。在Thauera、Leadbetterella、Neomegalonema和Amaricoccus等属中确定了所有原料中领先的PHA生产商。
{"title":"Influence of feedstock source on the development of polyhydroxyalkanoates-producing mixed microbial cultures in continuously stirred tank reactors","authors":"Elisa Clagnan,&nbsp;Fabrizio Adani","doi":"10.1016/j.nbt.2023.05.005","DOIUrl":"10.1016/j.nbt.2023.05.005","url":null,"abstract":"<div><p>Polyhydroxyalkanoates (PHAs) are the new frontier of bioplastic production; however, research is needed to develop and characterise efficient mixed microbial communities (MMCs) for their application with a multi-feedstock approach. Here, the performance and composition of six MMCs developed from the same inoculum on different feedstocks were investigated through Illumina sequencing to understand community development and identify possible redundancies in terms of genera and PHA metabolism. High PHA production efficiencies (&gt;80% mg COD<sub>PHA</sub> mg<sup>-1</sup> COD<sub>OA-consumed</sub>) were seen across all samples, but differences in the organic acids (OAs) composition led to different ratios of the monomers poly(3-hydroxybutyrate) (3HB) to poly(3-hydroxyvalerate) (3HV). Communities differed across all feedstocks, with enrichments in specific PHA-producing genera, but analysis of potential enzymatic activity identified a certain degree of functional redundancy, possibly leading to the general high efficiency seen in PHA production from all feedstocks. Leading PHAs producers across all feedstocks were identified in genera such as <em>Thauera</em>, <em>Leadbetterella</em>, <em>Neomegalonema</em> and <em>Amaricoccus</em>.</p></div>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9655740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Domain shifts in dermoscopic skin cancer datasets: Evaluation of essential limitations for clinical translation 皮肤镜下皮肤癌数据集的领域转移:评估临床翻译的基本限制
IF 5.4 2区 生物学 Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-09-25 DOI: 10.1016/j.nbt.2023.04.006
Katharina Fogelberg , Sireesha Chamarthi , Roman C. Maron , Julia Niebling , Titus J. Brinker

The limited ability of Convolutional Neural Networks to generalize to images from previously unseen domains is a major limitation, in particular, for safety-critical clinical tasks such as dermoscopic skin cancer classification. In order to translate CNN-based applications into the clinic, it is essential that they are able to adapt to domain shifts. Such new conditions can arise through the use of different image acquisition systems or varying lighting conditions. In dermoscopy, shifts can also occur as a change in patient age or occurrence of rare lesion localizations (e.g. palms). These are not prominently represented in most training datasets and can therefore lead to a decrease in performance. In order to verify the generalizability of classification models in real world clinical settings it is crucial to have access to data which mimics such domain shifts. To our knowledge no dermoscopic image dataset exists where such domain shifts are properly described and quantified. We therefore grouped publicly available images from ISIC archive based on their metadata (e.g. acquisition location, lesion localization, patient age) to generate meaningful domains. To verify that these domains are in fact distinct, we used multiple quantification measures to estimate the presence and intensity of domain shifts. Additionally, we analyzed the performance on these domains with and without an unsupervised domain adaptation technique. We observed that in most of our grouped domains, domain shifts in fact exist. Based on our results, we believe these datasets to be helpful for testing the generalization capabilities of dermoscopic skin cancer classifiers.

卷积神经网络推广到以前看不见的领域的图像的能力有限,这是一个主要限制,特别是对于安全关键的临床任务,如皮肤镜癌症分类。为了将基于CNN的应用程序转化为临床,它们必须能够适应领域的变化。这种新的条件可以通过使用不同的图像采集系统或改变照明条件而出现。在皮肤镜检查中,转移也可能发生在患者年龄的变化或罕见病变部位(如手掌)的发生上。这些在大多数训练数据集中没有得到显著的体现,因此可能导致性能下降。为了验证分类模型在现实世界临床环境中的可推广性,访问模拟这种领域变化的数据至关重要。据我们所知,没有一个皮肤镜图像数据集可以正确地描述和量化这种域偏移。因此,我们根据ISIC档案中的元数据(如采集位置、病变定位、患者年龄)对公开可用的图像进行分组,以生成有意义的域。为了验证这些域实际上是不同的,我们使用了多种量化措施来估计域偏移的存在和强度。此外,我们还分析了在使用和不使用无监督领域自适应技术的情况下,这些领域的性能。我们观察到,在我们的大多数分组域中,域偏移实际上是存在的。基于我们的结果,我们相信这些数据集有助于测试皮肤镜癌症分类器的泛化能力。
{"title":"Domain shifts in dermoscopic skin cancer datasets: Evaluation of essential limitations for clinical translation","authors":"Katharina Fogelberg ,&nbsp;Sireesha Chamarthi ,&nbsp;Roman C. Maron ,&nbsp;Julia Niebling ,&nbsp;Titus J. Brinker","doi":"10.1016/j.nbt.2023.04.006","DOIUrl":"10.1016/j.nbt.2023.04.006","url":null,"abstract":"<div><p>The limited ability of Convolutional Neural Networks to generalize to images from previously unseen domains is a major limitation, in particular, for safety-critical clinical tasks such as dermoscopic skin cancer classification. In order to translate CNN-based applications into the clinic, it is essential that they are able to adapt to domain shifts. Such new conditions can arise through the use of different image acquisition systems or varying lighting conditions. In dermoscopy, shifts can also occur as a change in patient age or occurrence of rare lesion localizations (e.g. palms). These are not prominently represented in most training datasets and can therefore lead to a decrease in performance. In order to verify the generalizability of classification models in real world clinical settings it is crucial to have access to data which mimics such domain shifts. To our knowledge no dermoscopic image dataset exists where such domain shifts are properly described and quantified. We therefore grouped publicly available images from ISIC archive based on their metadata (e.g. acquisition location, lesion localization, patient age) to generate meaningful domains. To verify that these domains are in fact distinct, we used multiple quantification measures to estimate the presence and intensity of domain shifts. Additionally, we analyzed the performance on these domains with and without an unsupervised domain adaptation technique. We observed that in most of our grouped domains, domain shifts in fact exist. Based on our results, we believe these datasets to be helpful for testing the generalization capabilities of dermoscopic skin cancer classifiers.</p></div>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10006368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A recombinant strain of Komagataeibacter xylinus ATCC 23770 for production of bacterial cellulose from mannose-rich resources 利用富含甘露糖的资源生产细菌纤维素的木霉菌ATCC 23770重组菌株
IF 5.4 2区 生物学 Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-09-25 DOI: 10.1016/j.nbt.2023.05.002
Fan Yang , Zhangjun Cao , Can Li , Lin Chen , Guochao Wu , Xingping Zhou , Feng F. Hong

The development of bacterial cellulose (BC) industrialization has been seriously affected by its production. Mannose/mannan is an essential component in many biomass resources, but Komagataeibacter xylinus uses mannose in an ineffective way, resulting in waste. The aim of this study was to construct recombinant bacteria to use mannose-rich biomass efficiently as an alternative and inexpensive carbon source in place of the more commonly used glucose. This strategy aimed at modification of the mannose catabolic pathway via genetic engineering of K. xylinus ATCC 23770 strain through expression of mannose kinase and phosphomannose isomerase genes from the Escherichia coli K-12 strain. Recombinant and wild-type strains were cultured under conditions of glucose and mannose respectively as sole carbon sources. The fermentation process and physicochemical properties of BC were investigated in detail in the strains cultured in mannose media. The comparison showed that with mannose as the sole carbon source, the BC yield from the recombinant strain increased by 84%, and its tensile strength and elongation were increased 1.7 fold, while Young's modulus was increased 1.3 fold. The results demonstrated a successful improvement in BC yield and properties on mannose-based medium compared with the wild-type strain. Thus, the strategy of modifying the mannose catabolic pathway of K. xylinus is feasible and has significant potential in reducing the production costs for industrial production of BC from mannose-rich biomass.

细菌纤维素的生产严重影响了其产业化的发展。甘露糖/甘露聚糖是许多生物质资源中的重要组成部分,但木霉菌以无效的方式使用甘露糖,导致浪费。本研究的目的是构建重组细菌,以有效利用富含甘露糖的生物质作为替代品和廉价的碳源,取代更常用的葡萄糖。该策略旨在通过表达来自大肠杆菌K-12菌株的甘露糖激酶和磷酸甘露糖异构酶基因,通过基因工程对木糖核酸酶ATCC 23770菌株进行甘露糖分解代谢途径的修饰。重组菌株和野生型菌株分别在葡萄糖和甘露糖作为唯一碳源的条件下培养。详细研究了甘露糖培养基中BC的发酵过程和理化性质。比较表明,以甘露糖为唯一碳源,重组菌株的BC产量提高了84%,拉伸强度和伸长率提高了1.7倍,杨氏模量提高了1.3倍。结果表明,与野生型菌株相比,在基于甘露糖的培养基上,BC产量和性能得到了成功的提高。因此,改变木糖精甘露糖分解代谢途径的策略是可行的,并且在降低富含甘露糖的生物质工业生产BC的生产成本方面具有重大潜力。
{"title":"A recombinant strain of Komagataeibacter xylinus ATCC 23770 for production of bacterial cellulose from mannose-rich resources","authors":"Fan Yang ,&nbsp;Zhangjun Cao ,&nbsp;Can Li ,&nbsp;Lin Chen ,&nbsp;Guochao Wu ,&nbsp;Xingping Zhou ,&nbsp;Feng F. Hong","doi":"10.1016/j.nbt.2023.05.002","DOIUrl":"10.1016/j.nbt.2023.05.002","url":null,"abstract":"<div><p>The development of bacterial cellulose (BC) industrialization has been seriously affected by its production. Mannose/mannan is an essential component in many biomass resources, but <em>Komagataeibacter xylinus</em> uses mannose in an ineffective way, resulting in waste. The aim of this study was to construct recombinant bacteria to use mannose-rich biomass efficiently as an alternative and inexpensive carbon source in place of the more commonly used glucose. This strategy aimed at modification of the mannose catabolic pathway via genetic engineering of <em>K. xylinus</em> ATCC 23770 strain through expression of mannose kinase and phosphomannose isomerase genes from the <em>Escherichia coli</em> K-12 strain. Recombinant and wild-type strains were cultured under conditions of glucose and mannose respectively as sole carbon sources. The fermentation process and physicochemical properties of BC were investigated in detail in the strains cultured in mannose media. The comparison showed that with mannose as the sole carbon source, the BC yield from the recombinant strain increased by 84%, and its tensile strength and elongation were increased 1.7 fold, while Young's modulus was increased 1.3 fold. The results demonstrated a successful improvement in BC yield and properties on mannose-based medium compared with the wild-type strain. Thus, the strategy of modifying the mannose catabolic pathway of <em>K. xylinus</em> is feasible and has significant potential in reducing the production costs for industrial production of BC from mannose-rich biomass.</p></div>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9642281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Valorization of bioethanol by-products to produce unspecific peroxygenase with Agrocybe aegerita: Technological and proteomic perspectives 生物乙醇副产物的增值利用绿草结霉生产非特异性过氧酶:技术和蛋白质组学观点
IF 5.4 2区 生物学 Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-09-25 DOI: 10.1016/j.nbt.2023.05.001
Sandra González-Rodríguez, Alba Trueba-Santiso, Thelmo A. Lu-Chau, María Teresa Moreira, Gemma Eibes

Unspecific peroxygenase (UPO) presents a wide range of biotechnological applications. This study targets the use of by-products from bioethanol synthesis to produce UPO by Agrocybe aegerita. Solid-state and submerged fermentations (SSF and SmF) were evaluated, achieving the highest titers of UPO and laccase in SmF using vinasse as nutrients source. Optimized UPO production of 331 U/L was achieved in 50% (v:v) vinasse with an inoculum grown for 14 days. These conditions were scaled-up to a 4 L reactor, achieving a UPO activity of 265 U/L. Fungal proteome expression was analyzed before and after UPO activity appeared by shotgun mass spectrometry proteomics. Laccase, dye-decolorizing peroxidases (DyP), lectins and proteins involved in reactive oxygen species (ROS) production and control were detected (in addition to UPO). Interestingly, the metabolism of complex sugars and nitrogen sources had a different activity at the beginning and end of the submerged fermentation.

非特异性过氧酶(UPO)具有广泛的生物技术应用。本研究旨在利用生物乙醇合成的副产物,由Agrocybe aegerita生产UPO。对固态发酵和深层发酵(SSF和SmF)进行了评估,以酒糟为营养源,在SmF中获得了最高滴度的UPO和漆酶。在接种物生长14天的50%(v:v)酒糟中实现了331U/L的优化UPO生产。将这些条件放大到4L反应器,实现265U/L的UPO活性。用鸟枪质谱蛋白质组学方法分析UPO活性出现前后真菌蛋白质组的表达。检测漆酶、染料脱色过氧化物酶(DyP)、凝集素和参与活性氧(ROS)产生和控制的蛋白质(除UPO外)。有趣的是,复合糖和氮源的代谢在深层发酵的开始和结束时具有不同的活性。
{"title":"Valorization of bioethanol by-products to produce unspecific peroxygenase with Agrocybe aegerita: Technological and proteomic perspectives","authors":"Sandra González-Rodríguez,&nbsp;Alba Trueba-Santiso,&nbsp;Thelmo A. Lu-Chau,&nbsp;María Teresa Moreira,&nbsp;Gemma Eibes","doi":"10.1016/j.nbt.2023.05.001","DOIUrl":"10.1016/j.nbt.2023.05.001","url":null,"abstract":"<div><p>Unspecific peroxygenase (UPO) presents a wide range of biotechnological applications. This study targets the use of by-products from bioethanol synthesis to produce UPO by <em>Agrocybe aegerita</em>. Solid-state and submerged fermentations (SSF and SmF) were evaluated, achieving the highest titers of UPO and laccase in SmF using vinasse as nutrients source. Optimized UPO production of 331 U/L was achieved in 50% (v:v) vinasse with an inoculum grown for 14 days. These conditions were scaled-up to a 4 L reactor, achieving a UPO activity of 265 U/L. Fungal proteome expression was analyzed before and after UPO activity appeared by shotgun mass spectrometry proteomics. Laccase, dye-decolorizing peroxidases (DyP), lectins and proteins involved in reactive oxygen species (ROS) production and control were detected (in addition to UPO). Interestingly, the metabolism of complex sugars and nitrogen sources had a different activity at the beginning and end of the submerged fermentation.</p></div>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9648732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A step closer to continuous buffer preparation from solids: Predicting powder compaction and how to prevent it 从固体中连续制备缓冲剂的一步:预测粉末压实和如何防止它
IF 5.4 2区 生物学 Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-09-25 DOI: 10.1016/j.nbt.2023.05.003
D. Komuczki , N. Hesse , J. Schmidt , P. Satzer

The preparation of buffer solutions used in the biopharmaceutical industry is typically performed manually by the addition of one or multiple buffering reagents to water. Recently, the adaptation of powder feeders for continuous solid feeding was demonstrated for continuous buffer preparation. However, the intrinsic characteristics of powders can change the stability of the process, due to the hygroscopic nature of some substances and humidity-induced caking and compaction behavior, but there is no simple and easy methodology available for predicting this behavior for buffer species. To predict which buffering reagents are suitable without special precautions and investigate their behavior, force displacement measurements were conducted with a customized rheometer over 18 h. While most of the eight investigated buffering reagents indicated uniform compaction, especially sodium acetate and dipotassium hydrogen phosphate (K2HPO4) showed a significant increase in yield stress after 2 h. Experiments conducted with a 3D printed miniaturized screw conveyor confirmed the increased yield stress measurements by visible compaction and failure of the feeding. By taking additional precautions and adjusting the design of the hopper, we demonstrated a highly linear profile of all buffering reagents over a duration of 12 and 24 h. We showed that force displacement measurements accurately predict the behavior of buffer components in continuous feeding devices for continuous buffer preparation and are a valuable tool to identify buffer components that need special precautions. Stable, precise feeding of all tested buffer components was demonstrated, highlighting the importance of identifying buffers that need a specialized setup with a rapid methodology.

生物制药工业中使用的缓冲溶液的制备通常通过向水中添加一种或多种缓冲试剂来手动进行。最近,在连续缓冲液制备中,证明了粉末给料机适用于连续固体进料。然而,由于某些物质的吸湿性以及湿度引起的结块和压实行为,粉末的固有特性会改变工艺的稳定性,但没有简单易行的方法来预测缓冲物质的这种行为。为了预测哪种缓冲试剂在没有特殊预防措施的情况下是合适的,并研究它们的行为,用定制的流变仪在18小时内进行了力-位移测量。虽然所研究的八种缓冲试剂中的大多数都显示出均匀的压实,特别是乙酸钠和磷酸氢二钾(K2HPO4)在2小时后显示出屈服应力的显著增加。用3D打印的小型螺旋输送机进行的实验证实,通过可见的压实和进给失败,屈服应力测量值增加。通过采取额外的预防措施和调整料斗的设计,我们展示了所有缓冲试剂在12和24小时内的高度线性分布。我们表明,力-位移测量准确地预测了用于连续缓冲液制备的连续进料装置中缓冲液组分的行为,是识别需要特殊预防措施的缓冲液组份的宝贵工具。证明了所有测试缓冲液成分的稳定、精确进料,强调了用快速方法确定需要专门设置的缓冲液的重要性。
{"title":"A step closer to continuous buffer preparation from solids: Predicting powder compaction and how to prevent it","authors":"D. Komuczki ,&nbsp;N. Hesse ,&nbsp;J. Schmidt ,&nbsp;P. Satzer","doi":"10.1016/j.nbt.2023.05.003","DOIUrl":"10.1016/j.nbt.2023.05.003","url":null,"abstract":"<div><p>The preparation of buffer solutions used in the biopharmaceutical industry is typically performed manually by the addition of one or multiple buffering reagents to water. Recently, the adaptation of powder feeders for continuous solid feeding was demonstrated for continuous buffer preparation. However, the intrinsic characteristics of powders can change the stability of the process, due to the hygroscopic nature of some substances and humidity-induced caking and compaction behavior, but there is no simple and easy methodology available for predicting this behavior for buffer species. To predict which buffering reagents are suitable without special precautions and investigate their behavior, force displacement measurements were conducted with a customized rheometer over 18 h. While most of the eight investigated buffering reagents indicated uniform compaction, especially sodium acetate and dipotassium hydrogen phosphate (K<sub>2</sub>HPO<sub>4</sub>) showed a significant increase in yield stress after 2 h. Experiments conducted with a 3D printed miniaturized screw conveyor confirmed the increased yield stress measurements by visible compaction and failure of the feeding. By taking additional precautions and adjusting the design of the hopper, we demonstrated a highly linear profile of all buffering reagents over a duration of 12 and 24 h. We showed that force displacement measurements accurately predict the behavior of buffer components in continuous feeding devices for continuous buffer preparation and are a valuable tool to identify buffer components that need special precautions. Stable, precise feeding of all tested buffer components was demonstrated, highlighting the importance of identifying buffers that need a specialized setup with a rapid methodology.</p></div>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9675445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
New biotechnology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1